HPPI

HedgePath Pharmaceuticals, Inc.

 
Common Stock SEC Reporting - Current
OTCQX U.S. OTCQX Advisor: Ellenoff Grossman & Schole LLP
Verified Company Profile 5/10/2017
Contact Info
  • 324 South Hyde Park Avenue
  • Suite 350
  • Tampa, FL 33606

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001042418
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: DE, USA
Year of Inc. 2013
Employees 3 a/o Jan 01, 2017
Company Officers/Contacts
Nicholas Virca CEO, President
Garrison J. Hasara CFO, Treasurer
James McNulty Secretary, Compliance Officer
Company Directors
E. Brendan Magrab Chairman
Stefan Cross
Robert D Martin
Dana Ono
W. Mark Watson
Company Notes
  • Sponsored for OTCQX by Ellenoff Grossman & Schole LLP on 12/07/2016
  • Formerly=Commonwealth Biotechnologies, Inc. until 8-2013
Service Providers
OTCQX Advisor
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY, 10105
USA

Accounting/Auditing Firm
Cherry, Bekaert & Holland, L.L.P.
401 East Jackson St
Suite 3400
Tampa, FL, 33602
United States

Legal Counsel
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY, 10105
United States

Investor Relations Firm
Not Available
HPPI Security Details
Share Structure
Market Value1 $144,143,714 a/o Aug 18, 2017
Authorized Shares 500,000,000 a/o Nov 16, 2016
Outstanding Shares 369,599,266 a/o Apr 27, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 58,569,902 a/o Apr 27, 2017
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
American Stock Transfer & Trust Company
Shareholders
Shareholders of Record 54 a/o Apr 27, 2017
Short Selling Data
Short Interest 9,594 (311.76%)
Jul 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security